{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Aspirin+325+mg+daily&page=3", "query": { "intervention": "Aspirin 325 mg daily", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 71, "total_pages": 8, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Aspirin+325+mg+daily&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Aspirin+325+mg+daily&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-10T14:28:01.215Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00474903", "title": "Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Barrett Esophagus", "Esophageal Cancer" ], "interventions": [ { "name": "acetylsalicylic acid", "type": "DRUG" }, { "name": "esomeprazole magnesium", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 122, "start_date": "2007-04", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2014-07-02", "last_synced_at": "2026-10-10T14:28:01.215Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00474903" }, { "nct_id": "NCT03244020", "title": "LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Sarcoma", "Soft Tissue Sarcoma", "Bone Sarcoma", "Bone Metastases", "Venous Thromboembolism", "Hematoma", "Anticoagulant-induced Bleeding" ], "interventions": [ { "name": "Aspirin 325mg", "type": "DRUG" }, { "name": "Enoxaparin 40Mg/0.4mL Prefilled Syringe", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2868, "start_date": "2018-02-16", "completion_date": "2028-07-01", "has_results": false, "last_update_posted_date": "2026-10-09", "last_synced_at": "2026-10-10T14:28:01.215Z", "location_count": 10, "location_summary": "Los Angeles, California • Tampa, Florida • New Orleans, Louisiana + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03244020" }, { "nct_id": "NCT04038489", "title": "COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer", "Estrogen Receptor-positive Breast Cancer" ], "interventions": [ { "name": "Aspirin", "type": "DRUG" }, { "name": "Tamoxifen Pill", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Virginia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2019-10-18", "completion_date": "2023-04-30", "has_results": false, "last_update_posted_date": "2021-11-22", "last_synced_at": "2026-10-10T14:28:01.215Z", "location_count": 1, "location_summary": "Charlottesville, Virginia", "locations": [ { "city": "Charlottesville", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04038489" }, { "nct_id": "NCT00626392", "title": "Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dyslipidemia" ], "interventions": [ { "name": "niacin extended-release (NER)", "type": "DRUG" }, { "name": "aspirin (ASA)", "type": "DRUG" }, { "name": "aspirin placebo (ASA Pbo)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 277, "start_date": "2008-02", "completion_date": "2008-04", "has_results": true, "last_update_posted_date": "2009-09-02", "last_synced_at": "2026-10-10T14:28:01.215Z", "location_count": 26, "location_summary": "Huntsville, Alabama • Scottsdale, Arizona • Tucson, Arizona + 22 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00626392" }, { "nct_id": "NCT00002527", "title": "Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Colorectal Cancer" ], "interventions": [ { "name": "aspirin", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "30 Years to 74 Years" }, "enrollment_count": 635, "start_date": "1993-05", "completion_date": "2006-01", "has_results": false, "last_update_posted_date": "2016-07-04", "last_synced_at": "2026-10-10T14:28:01.215Z", "location_count": 41, "location_summary": "Scottsdale, Arizona • San Francisco, California • Miami Beach, Florida + 37 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "San Francisco", "state": "California" }, { "city": "Miami Beach", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Peoria", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002527" }, { "nct_id": "NCT01809054", "title": "Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Primary Total Hip and Knee Arthroplasty" ], "interventions": [ { "name": "Arixtra", "type": "DRUG" }, { "name": "Pneumatic compression stockings", "type": "DEVICE" }, { "name": "Aspirin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "LifeBridge Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 54, "start_date": "2012-04", "completion_date": "2013-02", "has_results": true, "last_update_posted_date": "2014-04-21", "last_synced_at": "2026-10-10T14:28:01.215Z", "location_count": 2, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01809054" }, { "nct_id": "NCT01188304", "title": "A Study of Aleglitazar in Combination With Aspirin in Healthy Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteer" ], "interventions": [ { "name": "aleglitazar", "type": "DRUG" }, { "name": "aspirin", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "40 Years to 65 Years" }, "enrollment_count": 44, "start_date": "2010-07", "completion_date": "2010-10", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-10-10T14:28:01.215Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01188304" }, { "nct_id": "NCT01227629", "title": "PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atrial Fibrillation" ], "interventions": [ { "name": "dabigatran with ASA", "type": "DRUG" }, { "name": "warfarin", "type": "DRUG" }, { "name": "dabigatran without ASA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 502, "start_date": "2003-09", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-05-05", "last_synced_at": "2026-10-10T14:28:01.215Z", "location_count": 14, "location_summary": "Fayetteville, Arkansas • La Mesa, California • Pensacola, Florida + 11 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "La Mesa", "state": "California" }, { "city": "Pensacola", "state": "Florida" }, { "city": "Port Charlotte", "state": "Florida" }, { "city": "St. Petersburg", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01227629" }, { "nct_id": "NCT04045665", "title": "Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atrial Fibrillation", "Stroke", "Bleeding" ], "interventions": [ { "name": "Antiplatelet-only strategy", "type": "DRUG" }, { "name": "Oral Anticoagulant plus background antiplatelet therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3200, "start_date": "2019-12-13", "completion_date": "2026-08-31", "has_results": false, "last_update_posted_date": "2026-06-26", "last_synced_at": "2026-10-10T14:28:01.215Z", "location_count": 51, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Stanford, California + 40 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04045665" }, { "nct_id": "NCT00027066", "title": "Warfarin Versus Aspirin Recurrent Stroke Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Stroke" ], "interventions": [ { "name": "Active Aspirin", "type": "DRUG" }, { "name": "Active Warfarin", "type": "DRUG" }, { "name": "Aspirin placebo", "type": "DRUG" }, { "name": "Warfarin placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "30 Years to 85 Years" }, "enrollment_count": 2206, "start_date": "1993-06", "completion_date": "2001-11", "has_results": false, "last_update_posted_date": "2011-06-17", "last_synced_at": "2026-10-10T14:28:01.215Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00027066" } ] }